(365 nm) and has molecular formula C18H22O5. On the basis of the chemical and spectroscopical evidences to isoponcimarin was assigned the structure 7-(3 / -methyl-2',3'-epoxy-butyloxy)-8-(3''-methyl-2"-oxo-buthyl) coumarin (6) [1, 2] ; therefore isoponcimarin is a structural isomer of poncimarin, 7-(3'-methyl-2',3'-epoxy-butyloxy)-8-(3"-methyl-2",3"-epoxy-buthyl) coumarin (10) , isolated from the same natural source [3] and confirmed by total synthesis [4] , A number of natural coumarins were known, in which isopentenyl and geranyl side chains are present at various oxidation level [5] . The oxigenated function may be an epoxide group, a diol, a ketonic or an aldehydic group. It has been suggested a biogenetic pathway (not tested up to now) which from the epoxide derivative, via the diol derivative, give rise to the formation of the keto-or formyl-derivative by a pinacol-type rearrangement [6] .
In this way poncimarin (10) will be hydrolized to a diol derivative, which so far failed to be identified from extracts of Poncirus trifoliata.
On the other hand a direct rearrangement of the epoxide group may also be assumed: in this hypothesis poncimarin (10) may be considered the direct precursor of the isoponcimarin (6).
* Reprint requests to Dr. Prof. Manfred Mutter.
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In this paper we describe the synthesis of isoponcimarin obtaining a definite confirmation of the proposed structure 6 of this substance; in addition, we describe the synthesis of two other chemically correlated compounds.
The preparation (see Fig. 1 ) started from osthenol,
which an isopentenylic residue branched from the 8-position of the coumarin nucleus is already present; osthenol was prepared in good yield by
Claisen rearrangement of 7-(l,l-dimethyl-prop-2-enyloxy) coumarin [7] in boiling diethylaniline [4, 8] .
Osthenol was acetylated and then epoxidated by treatment with perbenzoic acid in chloroformic solution. The phenolic group ortho to the isopentenylic moiety must be protected before the epoxidation, because it was proved [9] that the direct epoxidation of osthenol affords to products of an The reaction of 4 with methyl iodide in acetonic solution and in the presence of K2CC>3 easily gave isomeranzin (isoauraptene), 7-methoxy-8-(2'-oxo-
Isomeranzin is a natural coumarin [12] and was previously prepared both by treatment of auraptene (meranzin), 7-methoxy-8-(2',3'-epoxy-3'-methylbutyl) coumarin, with 20% sulfuric acid [13] and by treatment of auraptenol, 7-methoxy-8-(2'-hydroxy-3'-methyl-but-3'-enyl) coumarin, in the same conditions [14] , as well as by total synthesis [11] . 
Experimental
Mps, determined in open capillary, are uncorrected. Silica gel plates 60 F-254 (Merck cat. 5715) were used for TLC, using as developing solvent a EtOAc-cyclohexane (35:65) mixture.
All the substances synthesized were analyzed for C, H and results were within ±0.3% of theoretical values.
X H NMR spectra were recorded at 60 MHz on Hitachi-Perkin Elmer R-24A or Bruker WP-60 spectrometer and are given in <5 relative to TMS as internal standard, coupling constants are given in Hz; all assignements are in agreement with relative peak areas and were applicable with decoupling experiments.
7-Acetoxy-8-(3'-methyl-but-2'-enyl)
coumarin (2) 7-Hydroxy-8-(3'-methyl-but-2-enyl) coumarin (osthenol) (2.5 g; 10.8 mmoles) was dissolved in acetic anhydride (20 ml) and pyridine (few drops) was added. The mixture was refluxed for 2 h and poured into ice-cold water stirring vigorously. The solid was collected by filtration, washed with water and crystallized from MeOH:
7-acetoxy-8-(3'-methyl-but-2'-enyl) coumarin, white needles, (2. 
-Acetoxy-8-( 3'-methyl-2' .3'-epoxy-butyl) coumarin (3)
7-Acetoxy-8-(3'-methyl-but-2'-enyl) coumarin (1.0 g; 3.7 mmoles) was dissolved in anhydrous CHCI3 (40 ml) and a volume of chloroformic solution containing the stoichiometric quantity of perbenzoic acid was added. The mixture was allowed to stand at room temperature for 2 h, when the mixture, monitored by TLC, appeared to be devoid of the starting material. The chloroformic solution was diluted with fresh chloroform to 150 ml and washed three times with 50 ml portions of saturated NaHC03 solution. The organic layer was dried (Na2S04) and the solvent eliminated under vacuum. The residue was dissolved in EtOAc and petr. ether (30-50 °C) was added to thickening; by long standing a crop of crystals was formed of 7-acetoxy-8- ( 
Rearrangement of the 7-acetoxy-8-(3'-methyl-2',3'-epoxy-butyl) coumarin
Into a dry ether solution of 7-acetoxy-8-(3'-methyl-2',3'-epoxy-butyl) coumarin (0.350 g; 1.2 mmoles) a stream of BF3 was bubbled as long as the solution became pale-yellow persistent in colour, while heat was developed.
The mixture was allowed to stand at room temperature 2 h. After this time the starting material appeared to be absent from the mixture by TLC, while a main product was formed other than a minor derivative with higher Rf value; both spots reacted when sprayed with the di-N02-phenyl-hydrazine reagent.
a) 7-Acetoxy-8-(3'-methyl-2'-oxo-butyl) coumarin
(4): The mixture was diluted to 200 ml with moist ether and extracted two times with water. The organic phase was dried (Na2S04) and the solvent eliminated. The residue was dissolved into a small volume of ether, petr. ether was added and by standing and cooling a crystalline solid was obtained (0.198 
b) 7-Acetoxy-8-(2'-formyl-2'-methyl-propyl)
coumarin (7): The mother liquors of crystallization of the keto derivatives (4) A number of fractions containing both the keto and the formyl derivative were then eluted. In the next fractions a further crop of pure 7-acetoxy-8-(3'-methyl-2'-oxo-butyl) coumarin, keto derivative (4) was obtained.
-( 3'-Methyl-but-2-enyl-oxy )-8-(3"-methyl-2"-oxobutyl) coumarin (5)
The 7-Acetoxy-8-(3'-methyl-2 / -oxo-butyl) coumarin (0.200 g; 0.69 mmoles) was dissolved in Me2CO (5 ml). To the acetonic solution an excess of finely powdered K2C03, a catalytic amount of KJ, few drops of H20 and an excess of 3-methyl-but-2-enylchloride (5 ml) were added and the mixture refluxed under energical stirring. More 3-methyl-but-2-enylchloride was added after 5' min. After 30' min the mixture monitored by TLC appeared to be devoid of the starting material. The mixture was cooled and K2CO3 was eliminated by filtration, washing it with fresh Me2CO. Filtrate and washings were evaporated under vacuum and the oily residue, which failed to crystallize from several solvents, was purified in a silica gel column by eluting with CHCI3. Fractions containing the main component were collected, the solvent eliminated and the solid by crystallization from w-hexane gave 7-(3'-methyl-but-2'-enyl-oxy)-8-(3"-methyl-2"-oxo-butyl) coumarin, m.p. 86 °C (0.18 g; 82%), iHNMR (CDCI3): 6 7.61 (1H; d; J = 9.5 Hz; H-4); 6 7.34 (1H; d; J = 8.5 Hz; H-5); 6 6.78 (1H; d; J = 8.5 Hz; H-6); 6 6.14 (1H; d; J = 9.5 Hz; H-3); 6 5.39 (1H; broadening t; J = 7 Hz; H-2'); 6 4.53 (2H; broadening d; J = 7 Hz; H-l'); 6 3.98 (2H; s; H-l"); 6 2.80 (1H; septet; J = 7 Hz; -CHMe2); 6 1.85 and 6 1.81 (3H each; ss; C = CMe2); 6 1.18 (6H; d; J = 7 Hz; -CHMe2).
(±) 7 -(3'-Methyl-2'-3'-epoxy-butyl-oxy)-8-(3"-methyl-2"-oxobutyl) coumarin (isoponcimarin) (6)
To a chloroformic solution of 7-(3'-methyl-but-2 / -enyl-oxy)-8-(3"-methyl-2"-oxo-butyl) coumarin (0.25 g; 0.8 mmoles) the stoichiometric amount of chloroformic solution of perbenzoic acid was added. The mixture was allowed to stand at room temperature for 1 h, when the starting material by TLC appeared to be completely consumed. The mixture was diluted with fresh CHCI3 and washed with two portions of saturated NaHCOs solution. The organic layer was dried and the solvent eliminated under vacuum. The residue was purified in a silica gel column by eluting with CHCI3. Fractions containing (TLC analysis) a single spot with an Rf value identical to that of natural isoponcimarin were deprived of the solvent and the residue by crystallization from w-hexane furnished (±) 7-(3'-methyl-2 / ,3'-epoxy-butyl-oxy)-8-(3"-methyl-2"-oxo-butyl) coumarin (0.167 g; 64%), m.p. 90 °C, X H NMR (CDCI3): 6 7.63 (1H; d; J = 9.5 Hz; H-4); 6 7.37 
